BetterLife Pharma (BETRF) Total Current Liabilities (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Total Current Liabilities of $4.9 million for Q2 2026, up 10.19% year-over-year from $4.4 million in Q2 2025, and up 0.79% quarter-over-quarter from $4.8 million in Q1 2026.
BetterLife Pharma (BETRF) Total Current Liabilities (2011 - 2026) Analysis & Trends
BetterLife Pharma's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $4.9 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 10.19% year-over-year to $4.9 million; the TTM figure through Apr 2026 stood at $4.9 million (up 10.19% YoY), while the FY2026 annual figure was $4.8 million, down 9.36% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $4.9 million, up from $4.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $5.4 million in Q1 2024, with the low at $3.3 million in Q1 2022.
- The 5-year median for Total Current Liabilities is $4.7 million (2022), against an average of $4.7 million.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities retreated 27.98% in 2022, then soared 61.88% in 2023.
- BetterLife Pharma's Total Current Liabilities stood at $4.7 million in 2022, then decreased by 0.91% to $4.7 million in 2023, then declined by 8.65% to $4.3 million in 2024, then climbed by 1.35% to $4.4 million in 2025, then grew by 11.33% to $4.9 million in 2026.
- Business Quant data shows BETRF's Total Current Liabilities at $4.9 million in Q2 2026, $4.8 million in Q1 2026, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 630.93 Mn |
| 10 | BetterLife Pharma | 33.62 Mn | 33.60 Mn | - | 4.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 4.85 Mn |
| Jan 31, 2026 | 4.81 Mn |
| Jul 31, 2025 | 4.36 Mn |
| Apr 30, 2025 | 4.40 Mn |
| Jan 31, 2025 | 5.31 Mn |
| Oct 31, 2024 | 4.30 Mn |
| Jul 31, 2024 | 4.57 Mn |
| Apr 30, 2024 | 4.70 Mn |
| Jan 31, 2024 | 5.43 Mn |
| Oct 31, 2023 | 4.71 Mn |
| Jul 31, 2023 | 5.10 Mn |
| Apr 30, 2023 | 4.81 Mn |
| Jan 31, 2023 | 5.30 Mn |
| Oct 31, 2022 | 4.75 Mn |
| Jul 31, 2022 | 4.93 Mn |
| Apr 30, 2022 | 4.58 Mn |
| Jan 31, 2022 | 3.27 Mn |
| Oct 31, 2021 | 2.95 Mn |
| Jul 31, 2021 | 3.53 Mn |
| Apr 30, 2021 | 3.69 Mn |